Suchergebnisse - "Ni, Yicheng"

PubPharm (445)

51

Molecular imaging of myocardial necrosis : an updated mini-review

enthalten in: Journal of drug targeting | 2020

von Zhang, D. | Jiang, C. | Feng, Y. | +2

52

Synthesis and Evaluation of Diindole-Based MRI Contrast Agent for In Vivo Visualization of Necrosis

enthalten in: Molecular imaging and biology | 2020

von Zhang, L. | Liu, L. | Zhang, D. | +7

53

Radiofrequency ablation with four electrodes as a building block for matrix radiofrequency ablation : Ex vivo liver experiments and finite element method modelling. Influence of electric and activation mode on coagulation size and geometry

enthalten in: Surgical oncology | 2020

von Mulier, S. | Possebon, R. | Jiang, Y. | +9

54

TREATMENT OF AVASCULAR OR HYPOVASCULAR MICRO-TUMORS

enthalten in: Europäisches Patentamt | 2020

von NI YICHENG

55

TREATMENT OF AVASCULAR OR HYPOVASCULAR MICRO-TUMORS

enthalten in: Europäisches Patentamt | 2020

von NI YICHENG

56

TREATMENT OF AVASCULAR OR HYPOVASCULAR MICRO-TUMORS

enthalten in: Europäisches Patentamt | 2020

von NI YICHENG

57

Imaging Cell Death : Focus on Early Evaluation of Tumor Response to Therapy

enthalten in: Bioconjugate chemistry | 2020

von Zhang, D. | Jin, Q. | Jiang, C. | +3

58

Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers : An Overview with Imaging-Histopathology Correlation

enthalten in: Diagnostics (Basel, Switzerland) | 2020

von Liu, Y. | Wang, S. | Zhao, X. | +7

59

Treatment of avascular or hypovascular micro-tumors

enthalten in: Europäisches Patentamt | 2020

von NI YICHENG

60

Hypothesis : What is the Best We Can Do with Hydroxychloroquine for COVID-19?

enthalten in: Clinical epidemiology | 2020

von Wang, S. | Mulier, S. | Jonscher, C. | +5